Fingerprint
Dive into the research topics of 'Homocysteine-lowering therapy and risk of recurrent stroke, myocardial infarction and death: The impact of age in the VISP trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Homocysteine-lowering therapy and risk of recurrent stroke, myocardial infarction and death: The impact of age in the VISP trial
Amytis Towfighi, Baback Arshi, Daniela Markovic, Bruce Ovbiagele
Research output: Contribution to journal › Article › peer-review
24
Scopus
citations